These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34287940)

  • 1. Predicting local failure of brain metastases after stereotactic radiosurgery with radiomics on planning MR images and dose maps.
    Wang H; Xue J; Qu T; Bernstein K; Chen T; Barbee D; Silverman JS; Kondziolka D
    Med Phys; 2021 Sep; 48(9):5522-5530. PubMed ID: 34287940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery.
    Mouraviev A; Detsky J; Sahgal A; Ruschin M; Lee YK; Karam I; Heyn C; Stanisz GJ; Martel AL
    Neuro Oncol; 2020 Jun; 22(6):797-805. PubMed ID: 31956919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
    Zhang Z; Yang J; Ho A; Jiang W; Logan J; Wang X; Brown PD; McGovern SL; Guha-Thakurta N; Ferguson SD; Fave X; Zhang L; Mackin D; Court LE; Li J
    Eur Radiol; 2018 Jun; 28(6):2255-2263. PubMed ID: 29178031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery.
    Huang CY; Lee CC; Yang HC; Lin CJ; Wu HM; Chung WY; Shiau CY; Guo WY; Pan DH; Peng SJ
    J Neurooncol; 2020 Feb; 146(3):439-449. PubMed ID: 32020474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases.
    Basree MM; Li C; Um H; Bui AH; Liu M; Ahmed A; Tiwari P; McMillan AB; Baschnagel AM
    J Neurooncol; 2024 Jun; 168(2):307-316. PubMed ID: 38689115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics.
    Peng L; Parekh V; Huang P; Lin DD; Sheikh K; Baker B; Kirschbaum T; Silvestri F; Son J; Robinson A; Huang E; Ames H; Grimm J; Chen L; Shen C; Soike M; McTyre E; Redmond K; Lim M; Lee J; Jacobs MA; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1236-1243. PubMed ID: 30353872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of 0.35 T magnetic resonance imaging radiomic features in stereotactic ablative body radiotherapy of pancreatic cancer: A pilot study.
    Simpson G; Spieler B; Dogan N; Portelance L; Mellon EA; Kwon D; Ford JC; Yang F
    Med Phys; 2020 Aug; 47(8):3682-3690. PubMed ID: 32329904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Response to Stereotactic Radiosurgery for Brain Metastases Using Convolutional Neural Networks.
    Cha YJ; Jang WI; Kim MS; Yoo HJ; Paik EK; Jeong HK; Youn SM
    Anticancer Res; 2018 Sep; 38(9):5437-5445. PubMed ID: 30194200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes.
    Garcia MA; Lazar A; Duriseti S; Raleigh DR; Hess CP; Fogh SE; Barani IJ; Nakamura JL; Larson DA; Theodosopoulos P; McDermott M; Sneed PK; Braunstein S
    J Neurosurg; 2017 Jun; 126(6):1756-1763. PubMed ID: 27367235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality MRI-based radiomics approach to predict the posttreatment response of lung cancer brain metastases to gamma knife radiosurgery.
    Jiang Z; Wang B; Han X; Zhao P; Gao M; Zhang Y; Wei P; Lan C; Liu Y; Li D
    Eur Radiol; 2022 Apr; 32(4):2266-2276. PubMed ID: 34978579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning.
    Jaberipour M; Soliman H; Sahgal A; Sadeghi-Naini A
    Sci Rep; 2021 Nov; 11(1):21620. PubMed ID: 34732781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases.
    Gutsche R; Lohmann P; Hoevels M; Ruess D; Galldiks N; Visser-Vandewalle V; Treuer H; Ruge M; Kocher M
    Radiother Oncol; 2022 Jan; 166():37-43. PubMed ID: 34801629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET/MRI Coregistration Helps Predict Response to Gamma Knife Radiosurgery in Patients With Brain Metastases.
    Leiva-Salinas C; Muttikkal TJE; Flors L; Puig J; Wintermark M; Patrie JT; Rehm PK; Sheehan JP; Schiff D
    AJR Am J Roentgenol; 2019 Feb; 212(2):425-430. PubMed ID: 30422717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a radiomics-based prediction pipeline for the response to stereotactic radiosurgery therapy in brain metastases.
    Du P; Liu X; Xiang R; Lv K; Chen H; Liu W; Cao A; Chen L; Wang X; Yu T; Ding J; Li W; Li J; Li Y; Yu Z; Zhu L; Liu J; Geng D
    Eur Radiol; 2023 Dec; 33(12):8925-8935. PubMed ID: 37505244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metastases from NSCLC treated with stereotactic radiotherapy: prediction mismatch between two different radiomic platforms.
    Carloni G; Garibaldi C; Marvaso G; Volpe S; Zaffaroni M; Pepa M; Isaksson LJ; Colombo F; Durante S; Lo Presti G; Raimondi S; Spaggiari L; de Marinis F; Piperno G; Vigorito S; Gandini S; Cremonesi M; Positano V; Jereczek-Fossa BA
    Radiother Oncol; 2023 Jan; 178():109424. PubMed ID: 36435336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases.
    Huber PE; Hawighorst H; Fuss M; van Kaick G; Wannenmacher MF; Debus J
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1339-49. PubMed ID: 11286842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
    Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
    J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.